Cutaneous and mucosal human papillomaviruses differ in net surface charge, potential impact on tropism

Virology Journal

Volumn 5, Issue , 2008, Pages

  Mistry, Nitesh ^a   Wibom, Carl ^a   Evander, Magnus ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CAPSID PROTEIN; HEPARIN; HPV L1 PROTEIN, HUMAN PAPILLOMAVIRUS; ONCOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL SURFACE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 5; IN VITRO STUDY; ISOELECTRIC POINT; MOUTH INFECTION; NONHUMAN; PH; PHYLOGENY; PLANT GROWTH; PROTEIN INTERACTION; SKIN INFECTION; SURFACE CHARGE; VIRUS CAPSID; VIRUS ENTRY; WART VIRUS; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; ISOLATION AND PURIFICATION; METABOLISM; MUCOSA; PAPILLOMA VIRUS; PHYSIOLOGY; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; SKIN; STATIC ELECTRICITY; VIRION; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; MIRIDAE; PAPILLOMAVIRIDAE;

CAPSID PROTEINS; CELL LINE; HEPARIN; HUMANS; ISOELECTRIC POINT; MODELS, MOLECULAR; MUCOUS MEMBRANE; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SKIN; STATIC ELECTRICITY; VIRION; VIRUS INTERNALIZATION;

EID: 54349098332     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-5-118     Document Type: Article

References (28)

1. Papillomaviruses and cancer: from basic studies to clinical application. H zur Hausen, Nat Rev Cancer 2002 2 5 342 350 10.1038/nrc798 12044010
2. Classification of papillomaviruses. EM de Villiers C Fauquet TR Broker HU Bernard H zur Hausen, Virology 2004 324 1 17 27 10.1016/j.virol.2004.03.033 15183049
3. Gene transfer using human papillomavirus pseudovirions varies according to virus genotype and requires cell surface heparan sulfate. AL Combita A Touze L Bousarghin PY Sizaret N Munoz P Coursaget, FEMS Microbiol Lett 2001 204 1 183 188 10.1111/j.1574-6968.2001.tb10883.x 11682199
4. Carboxy-fluorescein diacetate, succinimidyl ester labeled papillomavirus virus-like particles fluoresce after internalization and interact with heparan sulfate for binding and entry. P Drobni N Mistry N McMillan M Evander, Virology 2003 310 1 163 172 10.1016/S0042-6822(03)00114-4 12788640
5. Human papillomavirus infection requires cell surface heparan sulfate. T Giroglou L Florin F Schafer RE Streeck M Sapp, J Virol 2001 75 3 1565 1570 11152531 10.1128/JVI.75.3.1565-1570.2001
6. The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. JG Joyce JS Tung CT Przysiecki JC Cook ED Lehman JA Sands KU Jansen PM Keller, J Biol Chem 1999 274 9 5810 5822 10.1074/jbc.274.9. 5810 10026203
7. Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses. S Shafti-Keramat A Handisurya E Kriehuber G Meneguzzi K Slupetzky R Kirnbauer, J Virol 2003 77 24 13125 13135 14645569 10.1128/JVI.77.24.13125-13135.2003
8. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. M Evander IH Frazer E Payne YM Qi K Hengst NA McMillan, J Virol 1997 71 3 2449 2456 9032382
9. Human papillomaviruses bind a basal extracellular matrix component secreted by keratinocytes which is distinct from a membrane-associated receptor. TD Culp LR Budgeon ND Christensen, Virology 2006 347 1 147 159 10.1016/j.virol.2005.11.025 16376962
10. Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. TD Culp LR Budgeon MP Marinkovich G Meneguzzi ND Christensen, J Virol 2006 80 18 8940 8950 16940506 10.1128/JVI.00724-06
11. Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. PM Day CD Thompson CB Buck YY Pang DR Lowy JT Schiller, J Virol 2007 81 16 8784 8792 17553881 10.1128/JVI.00552-07
12. Surface-exposed amino acid residues of HPV16 L1 protein mediating interaction with cell surface heparan sulfate. M Knappe S Bodevin HC Selinka D Spillmann RE Streeck XS Chen U Lindahl M Sapp, J Biol Chem 2007 282 38 27913 27922 10.1074/jbc.M705127200 17640876
13. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. XS Chen RL Garcea I Goldberg G Casini SC Harrison, Mol Cell 2000 5 3 557 567 10.1016/S1097-2765(00)80449-9 10882140
14. Efficient intracellular assembly of papillomaviral vectors. CB Buck DV Pastrana DR Lowy JT Schiller, J Virol 2004 78 2 751 757 14694107 10.1128/JVI.78.2.751-757.2004
15. Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation. D Pyeon PF Lambert P Ahlquist, Proc Natl Acad Sci USA 2005 102 26 9311 9316 15958530 10.1073/pnas.0504020102
16. Generation of HPV pseudovirions using transfection and their use in neutralization assays. CB Buck DV Pastrana DR Lowy JT Schiller, Methods Mol Med 2005 119 445 462 16350417
17. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. P Boukamp RT Petrussevska D Breitkreutz J Hornung A Markham NE Fusenig, J Cell Biol 1988 106 3 761 771 2450098 10.1083/jcb.106.3.761
18. p53 point mutation in HPV negative human cervical carcinoma cell lines. T Crook D Wrede KH Vousden, Oncogene 1991 6 5 873 875 1646990
19. The anti-papillomavirus activity of human and bovine lactoferricin. N Mistry P Drobni J Naslund VG Sunkari H Jenssen M Evander, Antiviral Res 2007 75 3 258 265 10.1016/j.antiviral.2007.03.012 17481742
20. Carrageenan is a potent inhibitor of papillomavirus infection. CB Buck CD Thompson JN Roberts M Muller DR Lowy JT Schiller, PLoS Pathog 2006 2 7 e69 16839203 10.1371/journal.ppat.0020069
21. Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate. NA Patterson JL Smith MA Ozbun, J Virol 2005 79 11 6838 6847 15890923 10.1128/JVI.79.11.6838-6847.2005
22. Sulfated glycosaminoglycans of the vagina and perineal skin in pre- and postmenopausal women, according to genital prolapse stage. LR Bezerra PC Feldner Jr LM Kati MJ Girao MG Sartori EC Baracat GR de Lima HB Nader CP Dietrich, Int Urogynecol J Pelvic Floor Dysfunct 2004 15 4 266 271 15517672
23. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. JN Roberts CB Buck CD Thompson R Kines M Bernardo PL Choyke DR Lowy JT Schiller, Nat Med 2007 13 7 857 861 10.1038/nm1598 17603495
24. Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies. PM Day R Gambhira RB Roden DR Lowy JT Schiller, J Virol 2008 82 9 4638 4646 18305047 10.1128/JVI.00143-08
25. Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus. HC Selinka L Florin HD Patel K Freitag M Schmidtke VA Makarov M Sapp, J Virol 2007 81 20 10970 10980 17686860 10.1128/JVI.00998-07
26. Transcription Factor Binding Sites in the Long Control Region of Genital HPVs. M O'Conner SY Chan HU Bernard, Human papillomaviruses, 1995 compendium Los Alamos National Laboratory, Los Alamos, N. Mex, B HU, G Meyers HD, Baker C, Icenogle J, Halpern A, and Wheeler C, 1995 part III 21 40
27. Transcriptional activation of the human papillomavirus type 5 and 16 long control region in cells from cutaneous and mucosal origin. N Mistry M Simonsson M Evander, Virol J 2007 4 27 17352804 10.1186/1743-422X-4-27
28. Adenovirus type 37 binds to cell surface sialic acid through a charge-dependent interaction. N Arnberg AH Kidd K Edlund J Nilsson P Pring-Akerblom G Wadell, Virology 2002 302 1 33 43 10.1006/viro.2002.1503 12429514